QVT Financial’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

QVT Financial’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-133,690	Closed	-$3.08M	–	62
2020 Q4	$3.08M	Hold	133,690	–	–	0.17%	36
2020 Q3	$1.36M	Hold	133,690	–	–	0.17%	41
2020 Q2	$1.99M	Hold	133,690	–	–	0.34%	37
2020 Q1	$1.63M	Buy	+133,690	New	+$2.13M	0.38%	39

QVT Financial's PRVL Position: Q1 2021 in Review

QVT Financial sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 133,690 shares — an estimated $3.08M sold.

QVT Financial first reported a position in PRVL in Q1 2020 and held it in 4 quarters. The position peaked at $3.08M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

QVT Financial reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
QVT Financial sold 133,690 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $3.08M.
QVT Financial first reported a position in Prevail Therapeutics Inc. Common Stock in Q1 2020 and held it in 4 quarters.
QVT Financial's Prevail Therapeutics Inc. Common Stock position peaked at $3.08M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on QVT Financial's 13F filing for Q1 2021, filed 17 May 2021.